Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders

Int J Mol Sci. 2022 Jul 27;23(15):8281. doi: 10.3390/ijms23158281.

Abstract

Metformin is a first-line drug for treating type 2 diabetes mellitus (T2DM) and one of the most commonly prescribed drugs in the world. Besides its hypoglycemic effects, metformin also can improve cognitive or mood functions in some T2DM patients; moreover, it has been reported that metformin exerts beneficial effects on many neurological disorders, including major depressive disorder (MDD), Alzheimer's disease (AD) and Fragile X syndrome (FXS); however, the mechanism underlying metformin in the brain is not fully understood. Neurotransmission between neurons is fundamental for brain functions, and its defects have been implicated in many neurological disorders. Recent studies suggest that metformin appears not only to regulate synaptic transmission or plasticity in pathological conditions but also to regulate the balance of excitation and inhibition (E/I balance) in neural networks. In this review, we focused on and reviewed the roles of metformin in brain functions and related neurological disorders, which would give us a deeper understanding of the actions of metformin in the brain.

Keywords: metformin; neurological disorders; synapse; synaptic transmission.

Publication types

  • Review

MeSH terms

  • Brain
  • Depressive Disorder, Major* / drug therapy
  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Metformin* / pharmacology
  • Metformin* / therapeutic use
  • Nervous System Diseases* / drug therapy

Substances

  • Hypoglycemic Agents
  • Metformin